Immunogenicity to biologics: processes, impact on efficacy and safety, and management strategy 2013
05 Feb 2013
Online Event
Description
Topics
Impact on efficacy and safety
Overview on the processes and effects of immunogenicity
Regulatory guidelines on immunogenicity of biologics; FDA, ICH, CHMP, EMEA
Screening and confirmatory methods to measure immune responses
Risk management strategy
Who should Attend
R&D investigators
Executive management
Pre-clinical and clinical
Product development
QA/ QC
Regulatory affairs
Consultants
Marketing
Training
Past Events
Immunogenicity to biologics: processes, impact on efficacy and safety, and management strategy 2013 - 05 Feb 2013, Online Event (7967)
Important
Please, check "Immunogenicity to biologics: processes, impact on efficacy and safety, and management strategy" official website for possible changes, before making any traveling arrangements
